SOLIGENIX, INC. — Director's Dealing 2008

Dec 3, 2008

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2008-11-26

Reporting Person: CAVAZZA CLAUDIO (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	16666667	Indirect

Footnotes

F1: Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A. ("Sigma Tau"). Claudio Cavazza directly and indirectly owns 57% of Sigma Tau.